Cogent Biosciences, Inc.
COGT
$37.93
$0.621.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.69% | 18.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.94% | 4.13% | |||
| Operating Income | 0.94% | -4.13% | |||
| Income Before Tax | 0.97% | 5.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.97% | 5.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.97% | 5.02% | |||
| EBIT | 0.94% | -4.13% | |||
| EBITDA | 1.05% | -4.16% | |||
| EPS Basic | 6.07% | 12.14% | |||
| Normalized Basic EPS | 6.05% | 4.60% | |||
| EPS Diluted | 6.07% | 12.14% | |||
| Normalized Diluted EPS | 6.05% | 4.60% | |||
| Average Basic Shares Outstanding | 5.41% | 8.12% | |||
| Average Diluted Shares Outstanding | 5.41% | 8.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||